NCT03219723View on ClinicalTrials.gov

"Drug Use Surveillance of Takecab for Supplement to Helicobacter Pylori Eradication"

CompletedOBSERVATIONAL
Enrollment

560

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other
Interventions
DRUG

Vonoprazan

Vonoprazan tablets

DRUG

Amoxicillin hydrate

Amoxicillin hydrate (potency)

DRUG

Clarithromycin

Clarithromycin (potency)

DRUG

Metronidazole

Metronidazole

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY